Bay Colony Advisors’s Pacific Biosciences PACB Stock Holding History

Bay Colony Advisors’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$31.9K	Sell	19,000 -3,000	-14%	-$4.36K	﹤0.01%	492
2026 Q1	$29K	Hold	22,000	–	–	﹤0.01%	487
2025 Q4	$41.1K	Buy	+22,000	New	+$42.3K	﹤0.01%	496
2024 Q1	–	Sell	-25,526	Closed	-$250K	–	429
2023 Q4	$250K	Sell	25,526 -700	-3%	-$5.72K	0.05%	303
2023 Q3	$219K	Sell	26,226 -1,325	-5%	-$15.1K	0.05%	297
2023 Q2	$366K	Sell	27,551 -4,500	-14%	-$54.7K	0.09%	205
2023 Q1	$313K	Buy	32,051 +1,250	+4%	+$12.4K	0.08%	223
2022 Q4	$252K	Buy	30,801 +1,250	+4%	+$10.8K	0.07%	282
2022 Q3	$172K	Buy	29,551 +12,450	+73%	+$71.4K	0.05%	300
2022 Q2	$75K	Buy	17,101 +2,347	+16%	+$14.3K	0.02%	337
2022 Q1	$134K	Buy	14,754 +101	+0.7%	+$1.16K	0.03%	348
2021 Q4	$300K	Buy	14,653 +150	+1%	+$3.62K	0.09%	266
2021 Q3	$371K	Buy	14,503 +1,775	+14%	+$52.6K	0.12%	204
2021 Q2	$445K	Buy	12,728 +825	+7%	+$24K	0.15%	184
2021 Q1	$396K	Buy	+11,903	New	+$417K	0.15%	178

Other funds holding PACB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Bay Colony Advisors's PACB Position: Q2 2026 in Review

Bay Colony Advisors reduced its Pacific Biosciences (PACB) stake by 14% in Q2 2026, selling an estimated $4.36K and leaving 19,000 shares worth $31.9K. The position accounts for ﹤0.01% of the portfolio, ranked #492.

Bay Colony Advisors first reported a position in PACB in Q1 2021 and has held it in 15 quarters since. The position peaked at $445K in Q2 2021. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

Bay Colony Advisors held 19,000 shares of Pacific Biosciences worth $31.9K as of Q2 2026.
Bay Colony Advisors sold 3,000 Pacific Biosciences shares in Q2 2026, an estimated $4.36K.
Pacific Biosciences made up ﹤0.01% of Bay Colony Advisors's portfolio in Q2 2026, its #492 holding.
Bay Colony Advisors first reported a position in Pacific Biosciences in Q1 2021 and has held it in 15 quarters since.
Bay Colony Advisors's Pacific Biosciences position peaked at $445K in Q2 2021.
223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on Bay Colony Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.